Xoma reported $487.7M in Market Capitalization this June of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 384.69B 19.14B Mar/2026
Agenus USD 107M 16M Dec/2025
Agios Pharmaceuticals USD 2.01B 423M Mar/2026
BioMarin Pharmaceutical USD 10.86B 553M Mar/2026
Celldex Therapeutics USD 2.11B 307M Mar/2026
Curis USD 3M 10M Jun/2026
Eli Lilly USD 869.02B 146.97B Mar/2026
Emergent BioSolutions USD 125M 51M Dec/2023
Incyte USD 18.73B 660M Mar/2026
Novartis USD 307.76B 15.54B Mar/2026
Pfizer USD 153.81B 12.24B Mar/2026
Regeneron Pharmaceuticals USD 81.68B 560M Mar/2026